Prognostic parameters in recurrent colorectal cancer: A role of control or restaging by FDG-PET/CT

被引:3
作者
Hancerliogullari, Oguz [1 ]
Okuyucu, Kursat [2 ]
Ince, Semra [2 ]
Peker, Subutay [1 ]
Arslan, Nuri [2 ]
机构
[1] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Gen Surg, Ankara, Turkey
[2] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Nucl Med, Ankara, Turkey
关键词
colorectal neoplasms; neoplasm staging; prognosis; radiopharmaceuticals; recurrence; sensitivity and specificity; tomography; emission-computed; x-ray computed; CURATIVE RESECTION; FOLLOW-UP; F-18-FDG; CEA; STRATIFICATION; SURVEILLANCE; CARCINOMA; CA-19-9; CA19-9; COLON;
D O I
10.2298/VSP170817065H
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim. Colorectal cancer ranks the third most frequent cancer in the world. Approximately 40% of the disease recurs after surgical resection. Determination of predictive parameters for recurrence may help in stratification of patients and contribute to patient management. There are still very few studies which sought factors to predict the recurrence of colorectal cancer. The aim of this study was to examine the predefined risk factors in metastatic development and evaluate clinical significance of 18-fluorodeoxyglucose (FDG) uptake. Methods. The study was conducted with 56 patients for whom FDG-PET/CT (FDG-positron emission tomography/computed tomography) was requested for the suspicious recurrence or metastasis by routine conventional screening tests. Thirty three patients in whom recurrence/metastases were established with final histopathologic diagnosis formed the malignant group, and 23 patients with no recurrence/metastases formed the benign group. Risk factors [age, serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (Ca 19-9) levels, the maximum standardized uptake volume (SUVmax), tumor size (TS), CT/magnetic resonance imaging (MRI) findings, sex, primary tumor localization, lymphovascular invasion, perineural invasion (PNI), initial neoadjuvant therapy, lymph node initial metastasis (ILNM) excision, stage, tumor differentiation] were compared between these groups. Results. CEA, Ca 19-9, SUVmax, TS, PNI, ILNM, FDG uptake pattern, pattern of lesions on CT and tumor differentiation were found statistically significant by univariate analysis. After multivariate analysis, SUVmax and ILNM remained as the main risk parameters impacting recurrence/metastases. Mean SUVmax was 7.25 in the benign group, while it was 11.7 in the malignant group (p = 0.019). ILNM was present in 66.5% of patients in the malignant group, and in 30.5% of patients in the benign group (p = 0.015). For an estimated cut-off value of 6.3 and 12.5, respectively on ROC curve, the calculated specificities were 61% and 87%, respectively. Conclusion. ILNM and SUVmax are the main risk factors for recurrence of colorectal cancer and the patients with these factors must be followed up carefully. FDG-PET/CT is very sensitive for the detection of recurrence/metastases of colorectal cancer and SUVmax appears to improve its specificity.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 27 条
[1]   Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer [J].
Aghili, Mahdi ;
Izadi, Shahrzad ;
Madani, Hossein ;
Mortazavi, Hossein .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (01) :35-41
[2]  
Artiko V, 2015, HELL J NUCL MED, V18, P35
[3]   TIME TO LOCO-REGIONAL RECURRENCE AFTER RESECTION OF DUKES-B AND DUKES-C COLORECTAL-CANCER WITH OR WITHOUT ADJUVANT POSTOPERATIVE RADIOTHERAPY - A MULTIVARIATE REGRESSION-ANALYSIS [J].
BENTZEN, SM ;
BALSLEV, I ;
PEDERSEN, M ;
TEGLBJAERG, PS ;
HANBERGSORENSEN, F ;
BONE, J ;
JACOBSEN, NO ;
SELL, A ;
OVERGAARD, J ;
BERTELSEN, K ;
HAGE, E ;
FENGER, C ;
KRONBORG, O ;
HANSEN, L ;
HOSTRUP, H ;
NORGAARDPEDERSEN, B .
BRITISH JOURNAL OF CANCER, 1992, 65 (01) :102-107
[4]   Operative salvage for locoregional recurrent colon cancer after curative resection: An analysis of 100 cases [J].
Bowne, WB ;
Lee, B ;
Wong, WD ;
Ben-Porat, L ;
Shia, J ;
Cohen, AM ;
Enker, WE ;
Guillem, JG ;
Paty, PB ;
Weiser, MR .
DISEASES OF THE COLON & RECTUM, 2005, 48 (05) :897-909
[5]   Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer [J].
Bozkurt, Oktay ;
Inanc, Mevlude ;
Turkmen, Esma ;
Karaca, Halit ;
Berk, Veli ;
Duran, Ayse Ocak ;
Ozaslan, Ersin ;
Ucar, Mahmut ;
Hacibekiroglu, Ilhan ;
Eker, Baki ;
Baspinar, Osman ;
Ozkan, Metin .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (21) :9277-9281
[6]  
Chan K, 2012, Clin Oncol (R Coll Radiol), V24, P232, DOI 10.1016/j.clon.2011.11.008
[7]   Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence [J].
Chen, Chin-Hsin ;
Hsieh, Mon-Chau ;
Lai, Cheng-Chou ;
Yeh, Chien-Yuh ;
Chen, Jinn-Shiun ;
Hsieh, Pao-Shiu ;
Chiang, Jy-Ming ;
Tsai, Wen-Sy ;
Tang, Reiping ;
Changchien, Chung-Rong ;
Wang, Jeng-Yi .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (05) :567-571
[8]   Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection [J].
Chiaravalloti, Agostino ;
Fiorentini, Alessandro ;
Palombo, Erika ;
Rinino, Davide ;
Lacanfora, Annamaria ;
Danieli, Roberta ;
Di Russo, Carmen ;
Di Biagio, Daniele ;
Squillaci, Ettore ;
Schillaci, Orazio .
ONCOLOGY LETTERS, 2016, 12 (05) :4209-4213
[9]   USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA [J].
FILELLA, X ;
MOLINA, R ;
PIQUE, JM ;
GARCIAVALDECASAS, JC ;
GRAU, JJ ;
NOVELL, F ;
ASTUDILLO, E ;
DELACY, A ;
DANIELS, M ;
BALLESTA, AM .
TUMOR BIOLOGY, 1994, 15 (01) :1-6
[10]   Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection [J].
Fujita, S ;
Shimoda, T ;
Yoshimura, K ;
Yamamoto, S ;
Akasu, T ;
Moriya, Y .
JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (03) :127-131